Immutep Ltd (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Immutep Limited - ADR: Is Infosys Ltd. worth buying?
Item: Immutep Limited - ADR
Rating: 0.72783325
Author: Trendlyne DVM scores

about

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stim...

0.40 -0.01 (-2.44%)

88.67% Fall from 52W High

288.4K

XNAS Volume

XNAS 21 Jul, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Immutep Ltd (ADR) is on 30 Jul 2026 for the purpose of Immutep Ltd Fourth Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

12.3 / 100

Technically Bearish

16.8 / 100

No estimates available

Immutep Ltd (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..